• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Remedy finds good strategic partner for Control 2

REMEDYAnalyst Comment30.08.2024 klo 09.33
Atte RiikolaAnalyst
Discuss

Translation: Original comment published in Finnish on 8/30/2024 at 7:17 am EEST.

Remedy announced on Thursday a strategic partnership agreement with Annapurna Pictures for Control 2. Remedy will self-publish the game, but Annapurna will fund 50% of the game and have the rights to extend the Control and Alan Wake brands into film and television. In our projections, we had assumed that Remedy would fund Control 2 entirely on its own and raise additional funds to do so. The current agreement is more balanced from a risk perspective and eliminates the need for additional funding that we had anticipated. At the same time, the deal offers good royalty potential and a low-risk opportunity to reach new audiences through movies and TV series. Overall, we view the deal as good for Remedy and will update our forecasts accordingly in the near future.

The deal appears to offer a balanced risk/reward for Remedy

Under the terms of the agreement, Annapurna will fund 50% of the development budget for Control 2 and will have the rights to extend the Control and Alan Wake franchises into film and television. We expect the budget for the game to remain as previously announced (50 MEUR).

Remedy and Annapurna will split the game's revenue equally until the game's production budget is recouped. Remedy will then receive a larger share of game sales, since as the publisher of the game, the company is also responsible for marketing costs (at least 10-30% of the production budget for a typical AAA game). Thus, Remedy's share after recouping the development budget could be estimated at around 60-75% of sales revenues. In return, Annapurna will receive a greater share of audiovisual productions in which Remedy does not have to invest capital.

As part of the agreement, Annapurna will acquire an option to the television and film rights to Control and Alan Wake, as well as selected audiovisual licensing rights and related ancillary products. Remedy retains all intellectual property rights to Control and Alan Wake. As a result, Remedy has complete freedom to decide the fate of a potential Control 3 game project. Annapurna seems to be a quality producer of movies and TV series, so Remedy's game brands seem to be in good hands from that perspective.

Presumably, the signing of the contract will result in a higher volume of development fees for Q3 in proportion to the development done so far on Control 2. Considering this and future development fees, Remedy's cash position (Q2'24: 26.1 MEUR) appears to be sufficient to finance the next projects and to pay the two remaining installments for the Control rights to 505 Games.

Condor will apparently also be self-published

Based on the wording of the press release "self-publishing selected titles", Remedy will also self-publish Condor. We had expected Remedy to co-publish the project with a partner. In light of the Annapurna agreement, we continue to see the possibility that Condor will also bring in a partner in some form to share the financial risk. An interesting option, we think, would be to work with Sony or Microsoft. In this case, Condor could be immediately introduced to the masses on subscription services for these platforms (PlayStation Plus / Game Pass), Remedy would receive some compensation for this and Condor would potentially get a flying start in terms of player numbers.

Login required

This content is only available for logged in users

Create account

Remedy Entertainment is a game developer. Its operations are primarily focused on the development of action games, with a particular focus on 3D technology. Examples of games that the company has developed include several different versions of Alan Wake, Max Payne, and Control. Remedy also develops its own game engine and tooling technology that powers many of its games. The company was founded in 1995 and is headquartered in Espoo, Finland.

Read more on company page

Key Estimate Figures11.08.2024

202324e25e
Revenue33.952.852.1
growth-%-22.2 %55.6 %-1.4 %
EBIT (adj.)-28.6-2.6-8.9
EBIT-% (adj.)-84.4 %-5.0 %-17.0 %
EPS (adj.)-1.68-0.14-0.52
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.neg.neg.
EV/EBITDAneg.189.0neg.

Forum discussions

This is actually only true for the AAA side; for indie games, a demo is often a lifeline because it’s really the only way to generate interest...
9 hours ago
by xizted
6
Based on what has been shown and the information received so far, however, Control and Control Resonant are completely different games and genres...
13 hours ago
8
In his Inderes interview, Kasurinen at least said that the game shouldn’t be boring grinding, but rather positively surprising and provocative...
13 hours ago
by 1sarvinen
5
Usually, developers’ estimates of their game lengths are on the high side. Even if you shave some hours off the estimate, it still seems to ...
13 hours ago
by Relaaja
6
I’ve probably watched every video with spoilers. I believe Kasurinen said that you only play as the character Dylan in the game. Jesse, of course...
15 hours ago
by 1sarvinen
13
Yeah, it is a big game, especially by Remedy’s standards, but it’s right in line with the standards of the genre. It’s quite typical for the...
17 hours ago
by Jussi
11
Why do I have a gut feeling that the game has some kind of dual protagonist setup? The game’s length suggests that there isn’t enough for Dylan...
18 hours ago
by marmot76
4